NIH-funded research R01 grant

A new test for diagnosing Hepatitis C in outpatient clinics

Official title: Point-of-care Nucleic Acid Amplification Test for pangenomic Hepatitis C diagnosis in outpatient clinics

Funded at University of Washington · NIH-11131266 · Data updated 2026-11-12

This study is working on a quick and easy test for Hepatitis C that you can take without needing a blood draw or fancy lab equipment, so more people can get tested and treated, especially those who might not even know they have the virus.

More Hepatitis C research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startJuly 3, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$752,475
NIH project number5R01AI180936-02
Project IDNIH-11131266 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults who may be at risk for Hepatitis C infection or those who have not been previously diagnosed.

Less likely to help

Patients who have already been diagnosed and are receiving treatment for Hepatitis C may not benefit from this research.

What this research studies

This research focuses on developing a point-of-care nucleic acid amplification test (NAAT) for diagnosing Hepatitis C virus (HCV) infections in outpatient settings. The goal is to create a simple, rapid test that does not require blood draws or complex laboratory equipment, making it easier for patients to get tested and receive timely treatment. By improving access to accurate HCV testing, the research aims to identify more cases of HCV, especially among those who are asymptomatic and unaware of their infection. This approach could significantly enhance patient follow-up and linkage to effective antiviral treatments.

Why it matters

Potential benefit: If successful, this research could lead to faster and more accessible diagnosis of Hepatitis C, ultimately improving treatment rates and health outcomes for patients.

How similar studies have gone: Other research has shown success with similar point-of-care testing approaches, indicating a promising avenue for improving HCV diagnosis.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Posner, Jonathan D — University of Washington
  • Study coordinator: Posner, Jonathan D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.